IPAD-DB ID | C00654 |
Name | L-(-)-nicotine |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 0 H 1 4 N 2 |
Molecular Weight | 162.23 g/mol |
IUPAC Name | 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine |
InChI | InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2, 4, 6, 8, 10H, 3, 5, 7H2, 1H3/t10-/m0/s1 |
InChIKey | SNICXCGAKADSCV-JTQLQIEISA-N |
Canonical SMILES | CN1CCCC1C2=CN=CC=C2 |
PubChem CID | 89594 |
DrugBank Accession Number | DB00184 |
CAS Registry Number | 54-11-5 |
Molecular Weight(Computed by SwissADME) | 162.23 |
Hac(Computed by SwissADME) | 12 |
Volume(Computed by ADMETlab 2.0) | 178.488 |
Density(Computed by ADMETlab 2.0) | 0.908 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 11 |
Flexibility(Computed by ADMETlab 2.0) | 0.091 |
Stero Centers(Computed by ADMETlab 2.0) | 1 |
LogS(Computed by ADMETlab 2.0) | 0.573 |
LogD(Computed by ADMETlab 2.0) | 0.735 |
logP(Computed by ADMETlab 2.0) | 0.885 |
TPSA(Computed by SwissADME) | 16.13 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.46 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |